Breaking News

Otsuka Forms European R&D Ops

Increases global development and commercialization efforts

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Otsuka Pharmaceutical Co., Ltd. has formed Otsuka Europe Development and Commercialization Ltd. (OEDC) to support its European pharmaceutical business. OEDC will be Otsuka’s European R&D headquarters, working with Otsuka Pharmaceutical Europe Ltd. (OPEL) for the development and commercialization of its products. OEDC and OPEL are separate operations based just outside London. This business model aims to increase collaboration of the company’s global business.   “We are delighted ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters